期刊文献+

耻骨上经膀胱前列腺切除术治疗前列腺增生症216例临床资料分析 被引量:2

Analysis of the Clinical Data of 216 BPH Patients Who Underwent SPP
下载PDF
导出
摘要 目的分析近20年来耻骨上经膀胱前列腺切除术在治疗前列腺增生症(BPH)患者的临床应用效果变化。方法回顾性分析1992年1月—2012年1月首都医科大学附属北京安贞医院收治的216例行耻骨上经膀胱前列腺切除术的BPH患者的临床资料,根据治疗时间分为前10年组(n=100)和后10年组(n=116),对比分析两组患者的平均住院时间、住院费用、手术时间、术中出血量和术中及术后并发症等指标的差异。结果与前10年组比较,后10年组患者住院时间和手术时间缩短,住院费用增加,术中出血量减少,术中及术后并发症减少,差异均有统计学意义(P<0.05)。结论随着医疗水平的不断提高,耻骨上经膀胱前列腺切除术并发症越来越少,手术及住院时间缩短,手术质量不断上升,患者更加受益。 Objective To investigate the changes in the effect of suprapubic transvesical prostatectomy in the treatment of benign prostatic hyperplasia( BPH) in the last 20 years. Methods The clinical data of 216 BPH patients who received suprapubic transvesical prostatectomy in Beijing Anzhen Hospital Affiliated to Capital Medical University from January 1992 to January 2012 were analyzed retrospectively. According to the time of treatment,patients were divided into former 10- year group( n = 100) and latter 10- year group( n = 116). The indicators,such as average hospital stay,hospitalization expense,operation time,intranperative hemorrhage and operative complications,were compared between two groups of patients. Results Compared with cases in former 10- year group,the latter 10- year group had shorter operation time and hospital stay,more hospitalization expense,less intranperative hemorrhage and less operative complications( P〈0. 05). Conclusion With the improvement of medical care,the operative complications of suprapubic transvesical prostatectomy happen less and less, the surgery and hospital time are shorter and shorter,and quality of surgery is improving. All of these bring much benefit to patients.
作者 侯铸 姜永光 赵佳晖 罗勇 HOU Zhu JIANG Yong -guang ZHAO Jia - hui LUO Yong.(Department of Urology, Beijing Anzhen Hospital Affiliated to Capital Medical University, Beijing 100029, China Corresponding author: HOU Zhu, Department of Urology, Beijing Anzhen Hospital Affiliated to Capital Medical University, Beijing 100029, China)
出处 《中国全科医学》 CAS CSCD 北大核心 2016年第30期3719-3721,共3页 Chinese General Practice
关键词 前列腺增生 前列腺切除术 手术后并发症 Prostatic hyperplasia Prostatectomy Postoperative complications
  • 相关文献

参考文献9

  • 1陈业刚(综述),刘晓强(审校).代谢综合征与良性前列腺增生[J].中华男科学杂志,2010,16(12):1117-1119. 被引量:6
  • 2YU X, Elliott S P, Wilt T J, et al. Practice patterns in benign prostatic hyperplasia surgical therapy: the dramatic increase in minimally invasive technologies [J]. J Urol, 2008, 180 (1) : 241- 245.
  • 3CHOI S Y, KIM T H, MYUNG S C, et al. Impact of changing trends in medical therapy on surgery for benign prostatic hyperplasia over two decades [J].Korean J Urol, 2012, 53 (1): 23 -28.
  • 4RASSWEILER J, TEBER D, KUNTZ R, et al. Complications of transurethral resection of the prostate (TURP) - incidence, management, and prevention [J]. Eur Urol, 2006, 50 (5): 969 - 979.
  • 5ROCCO B, ALBO G, FERREIRA R C, et al. Recent advances in the surgical treatment of benign prostatic hyperplasia [ J ]. Ther Adv Urol, 2011, 3 (6): 263-272.
  • 6OKORIE C O, PISTERS L L Effect of modified suprapubic prostatectomy for benign prostatic hyperplasia on postoperative hemoglobin levels [ J ]. Can J Urol, 2010, 17 ( 4 ) : 5255 - 5258.
  • 7LACY J lkI, BOLE R, HENDRIEX L, et al. Retropubic prostatectomy for giant benign prostatic hyperplasia [ J ]. Can J Urol, 2015, 22 (5): 8000-8002.
  • 8SHIN Y S, ZHANG L T, ZHAO C, et al. Is an adjustment by transurethral surgery simultaneously needed during the suprapubic open prostatectomy? [J]. Prostate lnt, 2015, 3 (1): 31-34.
  • 9JOHNSON O K. Simultaneous open preperitoneal repair of inguinal hernia with open prostatectomy for benign prostate hyperplasia [ J ]. Frop Doct, 2015, 45 (1) : 42 -43.

二级参考文献16

  • 1郭利君,张祥华,李培军,那彦群.良性前列腺增生与原发性高血压的相关性研究[J].中华外科杂志,2005,43(2):108-111. 被引量:59
  • 2郭利君,张祥华,李培军,那彦群.高血压对良性前列腺增生组织中血管新生影响的研究[J].中华医学杂志,2005,85(9):606-609. 被引量:30
  • 3Parsons JK, Kashefi C. Physical activity, benign prostatic hyperplasia, and lower urinary tract symptoms. Eur Urol, 2008, 53 (6) : 1228-1235.
  • 4Natarajan V, Master V, Ogan K. Effects of obesity and weight loss in patients with nononcological urological disease. J Urol, 2009, 181 (6) : 2424-2429.
  • 5Xie LP, Bai Y, Zhang XZ, et al. Obesity and benign prostatic enlargement: A large obsen, ational study in China. Urology, 2007, 69(4): 680-684.
  • 6Parsons JK, Caner HB, Partin AW, et al. Metabolic factors associated with benign prostatic hyperplasia. J Clin Endocrinol Metab, 2006, 91 (7): 2562-2568.
  • 7Ozden C, Ozdal OL, Urgancioglu G, et al. The correlation between metabolic syndrome and prostatic growth in patients with benign prostatic hyperplasia. Eur Urol, 2007, 51 (1): 199-203.
  • 8Nandeesha H, Koner BC, Dorairajan LN, et al. Hyperinsulinemia and dyslipidemia in non-diabetic benign prostatic hyperplasia. Clin Chim Acta, 2006, 370( 1-2): 89-93.
  • 9Ilie CP, Chancellor MB. Perspective of Botox for treatment of male lower urinary tract symptoms. Curr Opin Urol, 2009, 19 ( 1 ) : 20-25.
  • 10Yono M, Yamamoto Y, Yoshida M, et al. Effects of doxazosin on blood flow and mRNA expression of nitric oxide synthase in the spontaneously hypertensive rat genitourinary tract. Life Sci, 2007, 81(3): 218-222.

共引文献5

同被引文献16

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部